These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25591474)

  • 61. Cyclosporine exacerbates ketamine toxicity in zebrafish: Mechanistic studies on drug-drug interaction.
    Robinson BL; Dumas M; Ali SF; Paule MG; Gu Q; Kanungo J
    J Appl Toxicol; 2017 Dec; 37(12):1438-1447. PubMed ID: 28569378
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Developmental Neurotoxicity of Methamidophos in the Embryo-Larval Stages of Zebrafish.
    He X; Gao J; Dong T; Chen M; Zhou K; Chang C; Luo J; Wang C; Wang S; Chen D; Zhou Z; Tian Y; Xia Y; Wang X
    Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28036051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Behavioral alterations of zebrafish larvae after early embryonic exposure to ketamine.
    Félix LM; Antunes LM; Coimbra AM; Valentim AM
    Psychopharmacology (Berl); 2017 Feb; 234(4):549-558. PubMed ID: 27933364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of embryonic exposure to polychlorinated biphenyls (PCBs) on larval zebrafish behavior.
    Lovato AK; Creton R; Colwill RM
    Neurotoxicol Teratol; 2016; 53():1-10. PubMed ID: 26561944
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacology of calcineurin antagonists.
    Kapturczak MH; Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of embryonic cyclosporine exposures on brain development and behavior.
    Clift DE; Thorn RJ; Passarelli EA; Kapoor M; LoPiccolo MK; Richendrfer HA; Colwill RM; Creton R
    Behav Brain Res; 2015 Apr; 282():117-24. PubMed ID: 25591474
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modulation of calcineurin signaling during development.
    Tucker Edmister S; Creton R
    Dev Neurobiol; 2022 Sep; 82(6):505-516. PubMed ID: 35785416
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
    Tucker Edmister S; Del Rosario Hernández T; Ibrahim R; Brown CA; Gore SV; Kakodkar R; Kreiling JA; Creton R
    Sci Rep; 2022 Apr; 12(1):6120. PubMed ID: 35449173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.
    Yu DY; Luo J; Bu F; Zhang W; Wei Q
    IUBMB Life; 2006 Jul; 58(7):429-33. PubMed ID: 16801218
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A zebrafish model for calcineurin-dependent brain function.
    Tucker Edmister S; Ibrahim R; Kakodkar R; Kreiling JA; Creton R
    Behav Brain Res; 2022 Jan; 416():113544. PubMed ID: 34425181
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-throughput analysis of behavior in zebrafish larvae: effects of feeding.
    Clift D; Richendrfer H; Thorn RJ; Colwill RM; Creton R
    Zebrafish; 2014 Oct; 11(5):455-61. PubMed ID: 25153037
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fish in behavior research: unique tools with a great promise!
    Gerlai R
    J Neurosci Methods; 2014 Aug; 234():54-8. PubMed ID: 24768578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Zebrafish models for translational neuroscience research: from tank to bedside.
    Stewart AM; Braubach O; Spitsbergen J; Gerlai R; Kalueff AV
    Trends Neurosci; 2014 May; 37(5):264-78. PubMed ID: 24726051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The CAVE artists.
    Lewis D
    Nat Med; 2014 Mar; 20(3):228-30. PubMed ID: 24603785
    [No Abstract]   [Full Text] [Related]  

  • 75. Zebrafish as an emerging model for studying complex brain disorders.
    Kalueff AV; Stewart AM; Gerlai R
    Trends Pharmacol Sci; 2014 Feb; 35(2):63-75. PubMed ID: 24412421
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.